Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Caveolin 1 | 17 | 2025 | 43 | 7.680 |
Why?
|
Retina | 29 | 2025 | 422 | 4.640 |
Why?
|
Intraocular Pressure | 6 | 2024 | 61 | 2.210 |
Why?
|
Glaucoma | 6 | 2024 | 52 | 2.020 |
Why?
|
Membrane Microdomains | 4 | 2023 | 36 | 1.710 |
Why?
|
Blood-Retinal Barrier | 4 | 2016 | 27 | 1.550 |
Why?
|
Caveolae | 3 | 2016 | 8 | 1.540 |
Why?
|
Neuroprotection | 2 | 2025 | 14 | 1.450 |
Why?
|
Fatty Acids | 6 | 2023 | 201 | 1.410 |
Why?
|
Cholesterol | 5 | 2023 | 182 | 1.340 |
Why?
|
Mice, Knockout | 17 | 2021 | 794 | 1.270 |
Why?
|
Animals | 56 | 2025 | 10080 | 1.240 |
Why?
|
Retinal Pigment Epithelium | 8 | 2024 | 91 | 1.220 |
Why?
|
Inflammation | 6 | 2024 | 608 | 1.170 |
Why?
|
Detergents | 5 | 2023 | 24 | 1.170 |
Why?
|
Aqueous Humor | 3 | 2024 | 24 | 1.140 |
Why?
|
Cell Membrane | 10 | 2023 | 236 | 1.070 |
Why?
|
Rod Cell Outer Segment | 8 | 2018 | 42 | 1.020 |
Why?
|
Mice | 32 | 2024 | 4473 | 1.010 |
Why?
|
Trabecular Meshwork | 4 | 2024 | 16 | 0.950 |
Why?
|
Mice, Inbred C57BL | 19 | 2024 | 1496 | 0.910 |
Why?
|
Lipopolysaccharides | 3 | 2021 | 156 | 0.860 |
Why?
|
Hot Temperature | 1 | 2023 | 84 | 0.800 |
Why?
|
Retinal Degeneration | 10 | 2019 | 142 | 0.790 |
Why?
|
Aging | 6 | 2024 | 952 | 0.770 |
Why?
|
Caveolins | 2 | 2016 | 3 | 0.760 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2021 | 2 | 0.760 |
Why?
|
Endothelial Cells | 3 | 2020 | 331 | 0.730 |
Why?
|
Homeodomain Proteins | 1 | 2021 | 74 | 0.730 |
Why?
|
Retinitis | 1 | 2020 | 8 | 0.710 |
Why?
|
Blotting, Western | 12 | 2020 | 506 | 0.710 |
Why?
|
Polymorphism, Genetic | 1 | 2020 | 163 | 0.680 |
Why?
|
Neurons | 1 | 2021 | 276 | 0.650 |
Why?
|
Uveitis | 2 | 2021 | 23 | 0.640 |
Why?
|
Light | 11 | 2016 | 117 | 0.620 |
Why?
|
DNA | 1 | 2020 | 365 | 0.620 |
Why?
|
Retinal Artery | 1 | 2018 | 10 | 0.610 |
Why?
|
Signal Transduction | 4 | 2025 | 1379 | 0.610 |
Why?
|
Ependymoglial Cells | 3 | 2019 | 29 | 0.590 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2018 | 77 | 0.590 |
Why?
|
Mechanotransduction, Cellular | 2 | 2021 | 24 | 0.580 |
Why?
|
Disease Models, Animal | 13 | 2024 | 1405 | 0.580 |
Why?
|
Transcription Factors | 1 | 2021 | 512 | 0.570 |
Why?
|
Muscle Contraction | 1 | 2018 | 167 | 0.560 |
Why?
|
Ocular Physiological Phenomena | 1 | 2016 | 2 | 0.550 |
Why?
|
Electroretinography | 10 | 2021 | 173 | 0.520 |
Why?
|
Gene Expression Regulation | 4 | 2017 | 626 | 0.510 |
Why?
|
Eye Proteins | 7 | 2014 | 197 | 0.510 |
Why?
|
Diabetic Retinopathy | 6 | 2017 | 108 | 0.480 |
Why?
|
Chemotactic Factors | 1 | 2014 | 7 | 0.470 |
Why?
|
Macular Degeneration | 4 | 2024 | 79 | 0.470 |
Why?
|
Photoreceptor Cells, Vertebrate | 3 | 2012 | 62 | 0.460 |
Why?
|
Immunohistochemistry | 6 | 2020 | 455 | 0.460 |
Why?
|
Retinal Vein | 1 | 2013 | 2 | 0.450 |
Why?
|
RNA | 1 | 2014 | 104 | 0.440 |
Why?
|
Sphingolipids | 3 | 2019 | 20 | 0.420 |
Why?
|
Tight Junctions | 2 | 2012 | 29 | 0.410 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 2 | 2016 | 54 | 0.410 |
Why?
|
Homeostasis | 2 | 2020 | 115 | 0.410 |
Why?
|
Lipids | 3 | 2017 | 198 | 0.400 |
Why?
|
Immunity, Innate | 1 | 2014 | 212 | 0.400 |
Why?
|
Cellular Microenvironment | 1 | 2012 | 5 | 0.400 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2012 | 10 | 0.400 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2017 | 96 | 0.380 |
Why?
|
Docosahexaenoic Acids | 5 | 2010 | 91 | 0.380 |
Why?
|
Humans | 24 | 2025 | 27119 | 0.330 |
Why?
|
Apoptosis | 6 | 2020 | 740 | 0.330 |
Why?
|
beta-Cyclodextrins | 3 | 2008 | 9 | 0.310 |
Why?
|
Neuroglia | 2 | 2023 | 30 | 0.310 |
Why?
|
Membrane Lipids | 1 | 2008 | 21 | 0.300 |
Why?
|
Retinal Cone Photoreceptor Cells | 3 | 2016 | 115 | 0.290 |
Why?
|
Consensus | 3 | 2024 | 69 | 0.290 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2008 | 95 | 0.280 |
Why?
|
Membrane Proteins | 4 | 2014 | 467 | 0.270 |
Why?
|
Flow Cytometry | 2 | 2020 | 285 | 0.270 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2014 | 65 | 0.270 |
Why?
|
Male | 15 | 2024 | 13022 | 0.260 |
Why?
|
Cytoskeleton | 3 | 2021 | 40 | 0.250 |
Why?
|
Rhodopsin | 5 | 2018 | 40 | 0.250 |
Why?
|
Sex Characteristics | 2 | 2024 | 163 | 0.250 |
Why?
|
Proteins | 1 | 2007 | 245 | 0.240 |
Why?
|
Ocular Hypertension | 2 | 2022 | 11 | 0.240 |
Why?
|
Organ Culture Techniques | 1 | 2024 | 55 | 0.240 |
Why?
|
Perfusion | 1 | 2024 | 43 | 0.240 |
Why?
|
Proteomics | 3 | 2020 | 177 | 0.240 |
Why?
|
Leukemia Inhibitory Factor | 2 | 2016 | 5 | 0.230 |
Why?
|
Cells, Cultured | 8 | 2021 | 976 | 0.230 |
Why?
|
Retinal Rod Photoreceptor Cells | 3 | 2016 | 91 | 0.230 |
Why?
|
Cattle | 6 | 2010 | 383 | 0.220 |
Why?
|
Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2003 | 7 | 0.220 |
Why?
|
Cyclodextrins | 1 | 2003 | 4 | 0.220 |
Why?
|
Transducin | 1 | 2003 | 13 | 0.220 |
Why?
|
Molecular Weight | 1 | 2023 | 118 | 0.210 |
Why?
|
Retinal Vessels | 4 | 2020 | 71 | 0.200 |
Why?
|
Neuroprotective Agents | 2 | 2013 | 52 | 0.200 |
Why?
|
TRPV Cation Channels | 1 | 2021 | 15 | 0.190 |
Why?
|
Receptors, CCR2 | 1 | 2021 | 4 | 0.190 |
Why?
|
Varicose Ulcer | 1 | 2021 | 1 | 0.190 |
Why?
|
Foot Ulcer | 1 | 2021 | 2 | 0.190 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 16 | 0.190 |
Why?
|
Immunity | 1 | 2021 | 26 | 0.190 |
Why?
|
Rats | 11 | 2017 | 1554 | 0.190 |
Why?
|
Oxidative Stress | 5 | 2018 | 635 | 0.180 |
Why?
|
Keratinocytes | 1 | 2021 | 32 | 0.180 |
Why?
|
Epithelial Cells | 3 | 2021 | 241 | 0.180 |
Why?
|
Cyclic N-Oxides | 3 | 2011 | 26 | 0.180 |
Why?
|
Nystagmus, Optokinetic | 1 | 2020 | 4 | 0.180 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 7 | 0.180 |
Why?
|
Transcriptional Regulator ERG | 1 | 2020 | 10 | 0.180 |
Why?
|
Visual Acuity | 1 | 2021 | 109 | 0.180 |
Why?
|
Cytokines | 2 | 2020 | 440 | 0.180 |
Why?
|
Intravitreal Injections | 1 | 2020 | 33 | 0.180 |
Why?
|
Oncogene Proteins | 1 | 2020 | 21 | 0.180 |
Why?
|
Eye | 1 | 2020 | 35 | 0.180 |
Why?
|
Amino Acid Oxidoreductases | 1 | 2020 | 4 | 0.180 |
Why?
|
Wound Healing | 1 | 2021 | 113 | 0.180 |
Why?
|
Drug Synergism | 1 | 2020 | 100 | 0.180 |
Why?
|
Repressor Proteins | 1 | 2021 | 114 | 0.170 |
Why?
|
Microscopy, Confocal | 1 | 2020 | 110 | 0.170 |
Why?
|
Phagocytosis | 2 | 2018 | 79 | 0.170 |
Why?
|
Salmonella typhimurium | 1 | 2020 | 68 | 0.170 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 70 | 0.170 |
Why?
|
Aldehydes | 4 | 2008 | 55 | 0.160 |
Why?
|
Mass Spectrometry | 1 | 2020 | 188 | 0.160 |
Why?
|
Adherens Junctions | 1 | 2019 | 8 | 0.160 |
Why?
|
Iodates | 2 | 2016 | 10 | 0.160 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 27 | 0.160 |
Why?
|
Cell Fractionation | 2 | 2018 | 18 | 0.160 |
Why?
|
Phenotype | 3 | 2019 | 667 | 0.160 |
Why?
|
Macrophages | 1 | 2021 | 279 | 0.160 |
Why?
|
Centrifugation, Density Gradient | 2 | 2017 | 26 | 0.150 |
Why?
|
Arterioles | 1 | 2018 | 61 | 0.150 |
Why?
|
Epithelium, Corneal | 1 | 2018 | 14 | 0.150 |
Why?
|
Cell Separation | 1 | 2018 | 55 | 0.150 |
Why?
|
Primary Cell Culture | 1 | 2018 | 27 | 0.150 |
Why?
|
Myeloid Cells | 1 | 2018 | 26 | 0.150 |
Why?
|
Corneal Diseases | 1 | 2018 | 21 | 0.150 |
Why?
|
Guidelines as Topic | 1 | 2018 | 44 | 0.150 |
Why?
|
STAT3 Transcription Factor | 2 | 2016 | 92 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2018 | 58 | 0.150 |
Why?
|
Injections, Intraperitoneal | 2 | 2016 | 34 | 0.150 |
Why?
|
Sphingosine | 2 | 2019 | 22 | 0.150 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 55 | 0.140 |
Why?
|
Sexual Behavior, Animal | 1 | 2017 | 30 | 0.140 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2018 | 110 | 0.140 |
Why?
|
Bone Morphogenetic Protein Receptors, Type II | 1 | 2017 | 1 | 0.140 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 73 | 0.140 |
Why?
|
Cell Culture Techniques | 1 | 2018 | 115 | 0.140 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 440 | 0.140 |
Why?
|
Carbonates | 1 | 2017 | 4 | 0.140 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2018 | 120 | 0.140 |
Why?
|
Vascular Remodeling | 1 | 2017 | 14 | 0.140 |
Why?
|
Protein Transport | 2 | 2016 | 153 | 0.140 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2014 | 129 | 0.140 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2017 | 128 | 0.130 |
Why?
|
Lipoproteins, LDL | 2 | 2016 | 36 | 0.130 |
Why?
|
Radiation Injuries, Experimental | 2 | 2007 | 31 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 77 | 0.130 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 291 | 0.130 |
Why?
|
Precipitin Tests | 2 | 2008 | 47 | 0.130 |
Why?
|
Female | 10 | 2024 | 14635 | 0.120 |
Why?
|
cis-trans-Isomerases | 2 | 2012 | 25 | 0.120 |
Why?
|
src-Family Kinases | 2 | 2008 | 71 | 0.120 |
Why?
|
Retinal Neovascularization | 1 | 2014 | 20 | 0.120 |
Why?
|
Pericytes | 1 | 2014 | 17 | 0.120 |
Why?
|
Fenofibrate | 1 | 2014 | 8 | 0.120 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2014 | 23 | 0.120 |
Why?
|
Biomarkers | 2 | 2018 | 738 | 0.120 |
Why?
|
Eye Infections, Bacterial | 1 | 2016 | 122 | 0.120 |
Why?
|
Mitochondria | 1 | 2017 | 342 | 0.120 |
Why?
|
PPAR alpha | 1 | 2014 | 32 | 0.110 |
Why?
|
Leukocytes | 1 | 2014 | 68 | 0.110 |
Why?
|
Lung | 1 | 2017 | 363 | 0.110 |
Why?
|
Tight Junction Proteins | 1 | 2013 | 9 | 0.110 |
Why?
|
Permeability | 1 | 2013 | 59 | 0.110 |
Why?
|
Reactive Oxygen Species | 3 | 2014 | 280 | 0.110 |
Why?
|
Propylene Glycols | 1 | 2013 | 3 | 0.110 |
Why?
|
Organ Specificity | 2 | 2010 | 81 | 0.110 |
Why?
|
Ceramides | 1 | 2013 | 24 | 0.100 |
Why?
|
Cell Line | 4 | 2021 | 681 | 0.100 |
Why?
|
Gene Expression | 3 | 2024 | 408 | 0.100 |
Why?
|
Retinal Ganglion Cells | 1 | 2012 | 26 | 0.100 |
Why?
|
Obesity | 1 | 2018 | 654 | 0.100 |
Why?
|
Rats, Sprague-Dawley | 6 | 2013 | 546 | 0.100 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 2008 | 165 | 0.100 |
Why?
|
Potassium | 1 | 2012 | 41 | 0.100 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2012 | 36 | 0.100 |
Why?
|
Retinal Diseases | 1 | 2012 | 45 | 0.090 |
Why?
|
Cell Differentiation | 1 | 2014 | 398 | 0.090 |
Why?
|
Phosphorylation | 3 | 2008 | 567 | 0.090 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2014 | 324 | 0.090 |
Why?
|
Mullerian Ducts | 1 | 2010 | 3 | 0.090 |
Why?
|
cdc42 GTP-Binding Protein | 2 | 2021 | 13 | 0.090 |
Why?
|
Carrier Proteins | 1 | 2011 | 246 | 0.080 |
Why?
|
Disease Susceptibility | 1 | 2010 | 72 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2010 | 177 | 0.080 |
Why?
|
Phytotherapy | 1 | 2008 | 22 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2008 | 101 | 0.080 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2008 | 22 | 0.070 |
Why?
|
Stress, Physiological | 1 | 2008 | 90 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2010 | 489 | 0.070 |
Why?
|
Microscopy, Immunoelectron | 1 | 2007 | 10 | 0.070 |
Why?
|
Curcumin | 1 | 2008 | 67 | 0.070 |
Why?
|
In Vitro Techniques | 1 | 2008 | 239 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2008 | 116 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 54 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2020 | 178 | 0.070 |
Why?
|
Hydroxylamine | 1 | 2007 | 9 | 0.070 |
Why?
|
Down-Regulation | 2 | 2021 | 198 | 0.070 |
Why?
|
Pyrimidines | 1 | 2008 | 121 | 0.070 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 247 | 0.070 |
Why?
|
Oxygen | 2 | 2020 | 230 | 0.070 |
Why?
|
Mutation | 1 | 2010 | 818 | 0.070 |
Why?
|
Proteolysis | 2 | 2017 | 55 | 0.070 |
Why?
|
Kidney | 1 | 2008 | 276 | 0.070 |
Why?
|
Immunoblotting | 2 | 2003 | 123 | 0.060 |
Why?
|
Amino Acid Sequence | 2 | 2006 | 675 | 0.060 |
Why?
|
Cell Survival | 3 | 2016 | 395 | 0.060 |
Why?
|
Octoxynol | 1 | 2005 | 9 | 0.060 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 133 | 0.060 |
Why?
|
Molecular Sequence Data | 2 | 2006 | 1037 | 0.060 |
Why?
|
Anterior Eye Segment | 1 | 2024 | 4 | 0.060 |
Why?
|
Receptor, Insulin | 1 | 2006 | 93 | 0.060 |
Why?
|
Phospholipids | 1 | 2005 | 75 | 0.060 |
Why?
|
Polymerase Chain Reaction | 2 | 2017 | 262 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2003 | 20 | 0.050 |
Why?
|
Darkness | 1 | 2003 | 17 | 0.050 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 130 | 0.050 |
Why?
|
Liver | 3 | 2010 | 424 | 0.050 |
Why?
|
Transcriptome | 1 | 2024 | 205 | 0.050 |
Why?
|
Capillaries | 2 | 2014 | 32 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2003 | 163 | 0.050 |
Why?
|
Tonometry, Ocular | 1 | 2022 | 8 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2003 | 200 | 0.050 |
Why?
|
Lipid Peroxidation | 3 | 2008 | 47 | 0.050 |
Why?
|
Xenopus laevis | 1 | 2021 | 47 | 0.050 |
Why?
|
Lipofuscin | 1 | 2001 | 7 | 0.050 |
Why?
|
Pigment Epithelium of Eye | 1 | 2001 | 15 | 0.050 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
Protein Binding | 1 | 2003 | 636 | 0.050 |
Why?
|
Diabetic Foot | 1 | 2021 | 17 | 0.050 |
Why?
|
Epithelium | 1 | 2021 | 39 | 0.050 |
Why?
|
NF-kappa B | 2 | 2014 | 187 | 0.050 |
Why?
|
Glucocorticoids | 1 | 2021 | 114 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2020 | 18 | 0.040 |
Why?
|
Exfoliation Syndrome | 1 | 2020 | 1 | 0.040 |
Why?
|
Human Umbilical Vein Endothelial Cells | 1 | 2020 | 50 | 0.040 |
Why?
|
Lysosomes | 2 | 2016 | 55 | 0.040 |
Why?
|
Blood Vessels | 1 | 2020 | 58 | 0.040 |
Why?
|
Indoles | 1 | 2020 | 98 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 1 | 2020 | 104 | 0.040 |
Why?
|
Aged | 2 | 2021 | 5222 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 2 | 2012 | 42 | 0.040 |
Why?
|
Cell Movement | 1 | 2021 | 353 | 0.040 |
Why?
|
Vacuoles | 1 | 2019 | 10 | 0.040 |
Why?
|
Extracellular Matrix | 1 | 2020 | 111 | 0.040 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2019 | 18 | 0.040 |
Why?
|
Endothelium | 1 | 2019 | 28 | 0.040 |
Why?
|
Cadherins | 1 | 2019 | 24 | 0.040 |
Why?
|
Fatty Acid Desaturases | 2 | 2009 | 15 | 0.040 |
Why?
|
Lysophospholipids | 1 | 2019 | 48 | 0.040 |
Why?
|
Models, Biological | 2 | 2017 | 448 | 0.040 |
Why?
|
Caenorhabditis elegans Proteins | 2 | 2009 | 55 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2010 | 264 | 0.040 |
Why?
|
Transgenes | 2 | 2008 | 59 | 0.040 |
Why?
|
Amyloidogenic Proteins | 1 | 2018 | 7 | 0.040 |
Why?
|
Mice, Inbred ICR | 1 | 2018 | 26 | 0.040 |
Why?
|
Tissue Preservation | 1 | 2018 | 3 | 0.040 |
Why?
|
Tissue and Organ Harvesting | 1 | 2018 | 6 | 0.040 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2018 | 2 | 0.040 |
Why?
|
Neuronal Plasticity | 1 | 2018 | 49 | 0.040 |
Why?
|
Chromatography, Thin Layer | 2 | 2010 | 18 | 0.040 |
Why?
|
Tissue Donors | 1 | 2018 | 24 | 0.040 |
Why?
|
Chromatography, Gas | 2 | 2010 | 17 | 0.040 |
Why?
|
Zonula Occludens-1 Protein | 1 | 2018 | 17 | 0.040 |
Why?
|
Blood-Brain Barrier | 1 | 2018 | 83 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2018 | 67 | 0.040 |
Why?
|
Fetus | 1 | 2018 | 77 | 0.040 |
Why?
|
Genome, Mitochondrial | 1 | 2017 | 16 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2018 | 89 | 0.040 |
Why?
|
Diet, High-Fat | 1 | 2018 | 134 | 0.040 |
Why?
|
DNA, Mitochondrial | 1 | 2017 | 82 | 0.030 |
Why?
|
Cell Shape | 1 | 2017 | 15 | 0.030 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2017 | 8 | 0.030 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2017 | 26 | 0.030 |
Why?
|
Acute Lung Injury | 1 | 2017 | 12 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2017 | 190 | 0.030 |
Why?
|
Dogs | 1 | 2018 | 505 | 0.030 |
Why?
|
Hippocampus | 1 | 2018 | 186 | 0.030 |
Why?
|
Actins | 1 | 2017 | 94 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2017 | 68 | 0.030 |
Why?
|
Evans Blue | 1 | 2016 | 7 | 0.030 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2016 | 17 | 0.030 |
Why?
|
Dextrans | 1 | 2016 | 22 | 0.030 |
Why?
|
Angiography | 1 | 2016 | 35 | 0.030 |
Why?
|
DNA Damage | 1 | 2017 | 149 | 0.030 |
Why?
|
Klebsiella pneumoniae | 1 | 2016 | 28 | 0.030 |
Why?
|
Opsins | 1 | 2016 | 18 | 0.030 |
Why?
|
Cathepsin D | 1 | 2016 | 3 | 0.030 |
Why?
|
Coloring Agents | 1 | 2016 | 35 | 0.030 |
Why?
|
Phagosomes | 1 | 2016 | 6 | 0.030 |
Why?
|
Receptors, Transferrin | 1 | 2016 | 17 | 0.030 |
Why?
|
Sus scrofa | 1 | 2016 | 12 | 0.030 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 38 | 0.030 |
Why?
|
Vision, Ocular | 1 | 2016 | 27 | 0.030 |
Why?
|
Alzheimer Disease | 1 | 2018 | 211 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2017 | 153 | 0.030 |
Why?
|
Age Factors | 1 | 2018 | 721 | 0.030 |
Why?
|
Circadian Rhythm | 1 | 2016 | 76 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2017 | 189 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2016 | 115 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2016 | 123 | 0.030 |
Why?
|
Cognitive Dysfunction | 1 | 2018 | 259 | 0.030 |
Why?
|
NADPH Oxidases | 1 | 2014 | 69 | 0.030 |
Why?
|
Endophthalmitis | 1 | 2016 | 119 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 253 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2014 | 80 | 0.030 |
Why?
|
Gene Deletion | 1 | 2014 | 116 | 0.030 |
Why?
|
Middle Aged | 2 | 2017 | 6900 | 0.030 |
Why?
|
Fingolimod Hydrochloride | 1 | 2013 | 5 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 1570 | 0.030 |
Why?
|
Adult | 2 | 2017 | 7492 | 0.030 |
Why?
|
Cytokine Receptor gp130 | 1 | 2012 | 5 | 0.030 |
Why?
|
Glycation End Products, Advanced | 1 | 2012 | 16 | 0.030 |
Why?
|
Glycosylation | 1 | 2012 | 69 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2012 | 77 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 142 | 0.020 |
Why?
|
Acyltransferases | 1 | 2011 | 24 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 2011 | 34 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2012 | 355 | 0.020 |
Why?
|
Leukostasis | 1 | 2010 | 3 | 0.020 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2010 | 29 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 143 | 0.020 |
Why?
|
Testis | 1 | 2010 | 39 | 0.020 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 57 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2010 | 131 | 0.020 |
Why?
|
Body Weight | 1 | 2010 | 248 | 0.020 |
Why?
|
Skin | 1 | 2010 | 140 | 0.020 |
Why?
|
Safflower Oil | 1 | 2008 | 3 | 0.020 |
Why?
|
Cytoprotection | 1 | 2008 | 24 | 0.020 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2008 | 13 | 0.020 |
Why?
|
Light Signal Transduction | 1 | 2008 | 8 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 195 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2008 | 149 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2008 | 86 | 0.020 |
Why?
|
Dietary Fats | 1 | 2008 | 58 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2008 | 61 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2010 | 648 | 0.020 |
Why?
|
Spin Labels | 1 | 2007 | 19 | 0.020 |
Why?
|
Dietary Supplements | 1 | 2008 | 221 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2006 | 132 | 0.020 |
Why?
|
Free Radical Scavengers | 1 | 2005 | 23 | 0.020 |
Why?
|
Immunoenzyme Techniques | 1 | 2005 | 65 | 0.020 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2006 | 48 | 0.020 |
Why?
|
Tyrosine | 1 | 2006 | 91 | 0.020 |
Why?
|
Nitrogen Oxides | 1 | 2005 | 40 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 2626 | 0.010 |
Why?
|
Brain | 1 | 2010 | 710 | 0.010 |
Why?
|
Arrestin | 1 | 2001 | 11 | 0.010 |
Why?
|
Photobiology | 1 | 2001 | 2 | 0.010 |
Why?
|
Free Radicals | 1 | 2001 | 39 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 283 | 0.010 |
Why?
|
Antioxidants | 1 | 2001 | 220 | 0.010 |
Why?
|